<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zhps</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал прикладной спектроскопии</journal-title><trans-title-group xml:lang="en"><trans-title>Zhurnal Prikladnoii Spektroskopii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0514-7506</issn><publisher><publisher-name>B. I. Stepanov Institute of Physics of the National Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">zhps-1610</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СПЕКТРОСКОПИЯ В БИОЛОГИИ И МЕДИЦИНЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SPECTROSCOPY IN BIOLOGY AND MEDICINE</subject></subj-group></article-categories><title-group><article-title>Спектральные свойства биокрасителей при формировании новых препаративных форм пролекарств</article-title><trans-title-group xml:lang="en"><trans-title>Spectral Properties of Biodyes in the Formation of New Preparative Forms of Prodrugs</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герловский</surname><given-names>Д. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Gerlovsky</surname><given-names>D. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Минск</p></bio><bio xml:lang="en"><p>Minsk</p></bio><email xlink:type="simple">al_h@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвинко</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Litvinko</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Минск</p></bio><bio xml:lang="en"><p>Minsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт биоорганической химии НАН Беларуси</institution></aff><aff xml:lang="en"><institution>Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>08</month><year>2024</year></pub-date><volume>91</volume><issue>4</issue><fpage>553</fpage><lpage>562</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Герловский Д.О., Литвинко Н.М., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Герловский Д.О., Литвинко Н.М.</copyright-holder><copyright-holder xml:lang="en">Gerlovsky D.O., Litvinko N.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://zhps.ejournal.by/jour/article/view/1610">https://zhps.ejournal.by/jour/article/view/1610</self-uri><abstract><p>Охарактеризованы спектральные и бактерицидные свойства ряда биокрасителей, таких как бромфеноловый синий, амидо черный 10В, метилтимоловый синий, фуксин основной, хромовый темно-синий, эозин, краситель индиго, бромфеноловый красный. Показано, что включение эозина, бромфенолового красного, индиго, рифампицина во внутреннее пространство фосфолипидных наноконтейнеров приводит к нивелированию характерных максимумов поглощения в видимой или ультрафиолетовой области для спектров этих соединений в виде водного раствора, что позволяет осуществлять визуальный и спектрофотометрический контроль за процессом включения пролекарства внутрь липосом. Конструирование ряда надмолекулярных форм пролекарств, которые представляют собой мицеллы и липосомы из модифицированных форм бактерицидного нуклеозида бривудина в различных сочетаниях, показало целесообразность использования в качестве маркера красителя индиго. Это позволило определить липосомы, сформированные из эквимолярной смеси липоконъюгата димиристоилфосфатидилбривудина с димиристоилфосфатидилхолином в качестве препаративной формы потенциального пролекарства, наиболее эффективно подавляющей рост клеток золотистого стафилококка.</p></abstract><trans-abstract xml:lang="en"><p>The spectral and bactericidal properties of a number of biodyes such as bromophenol blue, amido black 10 B, methyl thymol blue, basic fuchsin, chrome dark blue, eosin, dye (indigo), bromophenol red were characterized. It has been shown that the inclusion of eosin, bromophenol red, indigo and rifampicin into the internal space of phospholipid nanocontainers leads to leveling of the characteristic absorption maxima in the visible or ultraviolet region for the spectra of these compounds in the form of an aqueous solution. This allows visual and spectrophotometric monitoring of the process of the prodrug incorporation into liposomes. The construction of a number of supramolecular forms of prodrugs, which are micelles and liposomes from modified forms of the bactericidal nucleoside brivudine in various combinations, showed the feasibility of using indigo as a dye marker. This made it possible to identify liposomes formed from an equimolar mixture of dimyristoylphosphatidylbrivudine lipoconjugate with dimyristoylphosphatidylcholine as a potential prodrug formulation that most effectively inhibits the growth of Staphylococcus aureus cells.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>липосома</kwd><kwd>биокраситель</kwd><kwd>липонуклеозид</kwd><kwd>бактерицидное действие</kwd></kwd-group><kwd-group xml:lang="en"><kwd>liposome</kwd><kwd>biodye</kwd><kwd>liponucleoside</kwd><kwd>bactericidal effect</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">R. L Ferreira, G. S. Rezende, M. S. Folhas Damas, M. Oliveira-Silva, A. Pitondo-Silva, M. C. A. Brito, E. Leonardecz, F. R. de Góes, E. Boni Campanini, I. Malavazi, A. F. da Cunha, Maria-Cristina da Silva Pranchevicius. Front. Microbiol., 11 (2020) 956, doi: 10.3389/fmicb.2020.00956. eCollection 2020</mixed-citation><mixed-citation xml:lang="en">R. L Ferreira, G. S. Rezende, M. S. Folhas Damas, M. Oliveira-Silva, A. Pitondo-Silva, M. C. A. Brito, E. Leonardecz, F. R. de Góes, E. Boni Campanini, I. Malavazi, A. F. da Cunha, Maria-Cristina da Silva Pranchevicius. Front. Microbiol., 11 (2020) 956, doi: 10.3389/fmicb.2020.00956. eCollection 2020</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Липосомы в биологических системах, под ред. Г. Грегориадиса, А. К. Аллисона, Москва, Медицина (1983)</mixed-citation><mixed-citation xml:lang="en">Липосомы в биологических системах, под ред. Г. Грегориадиса, А. К. Аллисона, Москва, Медицина (1983)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">S. Shah, V. Dhawan, R. Holm, M. S. Nagarsenker, Y. Perrie. Adv. Drug. Deliv. Rev., 154-155 (2020) 102—122, doi: 10.1016/j.addr.2020.07.002. Epub 2020 Jul 8. PMID: 32650041</mixed-citation><mixed-citation xml:lang="en">S. Shah, V. Dhawan, R. Holm, M. S. Nagarsenker, Y. Perrie. Adv. Drug. Deliv. Rev., 154-155 (2020) 102—122, doi: 10.1016/j.addr.2020.07.002. Epub 2020 Jul 8. PMID: 32650041</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">M. Alhariri, A. Azghani, A. Omri. Expert Opin. Drug. Deliv., 10-11 (2013) 1515—1532, doi: 10.1517/17425247.2013.822860</mixed-citation><mixed-citation xml:lang="en">M. Alhariri, A. Azghani, A. Omri. Expert Opin. Drug. Deliv., 10-11 (2013) 1515—1532, doi: 10.1517/17425247.2013.822860</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">D. Guimarães, A. Cavaco-Paulo, E. Nogueira. Int. J. Pharm., 601 (2021) 120571, doi: 10.1016/j.ijpharm.2021.120571</mixed-citation><mixed-citation xml:lang="en">D. Guimarães, A. Cavaco-Paulo, E. Nogueira. Int. J. Pharm., 601 (2021) 120571, doi: 10.1016/j.ijpharm.2021.120571</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">M. Li, C. Du, N. Guo, Y. Teng, X. Meng, H. Sun, S. Li, P. Yu, H. Galons. Eur. J. Med. Chem., 164 (2019) 640—653, doi: 10.1016/j.ejmech.2019.01.007</mixed-citation><mixed-citation xml:lang="en">M. Li, C. Du, N. Guo, Y. Teng, X. Meng, H. Sun, S. Li, P. Yu, H. Galons. Eur. J. Med. Chem., 164 (2019) 640—653, doi: 10.1016/j.ejmech.2019.01.007</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">M. L. Immordino, F. Dosio, L. Cattel. Int. J. Nanomedicine, 1, N 3 (2006) 297—315, PMID: 17717971</mixed-citation><mixed-citation xml:lang="en">M. L. Immordino, F. Dosio, L. Cattel. Int. J. Nanomedicine, 1, N 3 (2006) 297—315, PMID: 17717971</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">B. Almeida, O. K. Nag, K. E. Rogers, J. B. Delehanty. Molecules, 25, N 23 (2020) 5672, doi: 10.3390/molecules25235672.PMID: 33271886</mixed-citation><mixed-citation xml:lang="en">B. Almeida, O. K. Nag, K. E. Rogers, J. B. Delehanty. Molecules, 25, N 23 (2020) 5672, doi: 10.3390/molecules25235672.PMID: 33271886</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">D. E. Large, R. G. Abdelmessih, E. A. Fink, D. T. Auguste. Adv. Drug. Deliv. Rev., 176 (2021) 113851, doi: 10.1016/j.addr.2021.113851</mixed-citation><mixed-citation xml:lang="en">D. E. Large, R. G. Abdelmessih, E. A. Fink, D. T. Auguste. Adv. Drug. Deliv. Rev., 176 (2021) 113851, doi: 10.1016/j.addr.2021.113851</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">R. Vogel, J. Savage, J. Muzard, G. Della Camera, G. Vella, A. Law, M. Marchioni, D. Mehn, O. Geiss, B. Peacock, D. Aubert, L. Calzolai, F. Caputo, A. Prina‐Mello. J. Extracell. Vesicles, 10, N 3 (2021) e12052, doi: 10.1002/jev2.120521</mixed-citation><mixed-citation xml:lang="en">R. Vogel, J. Savage, J. Muzard, G. Della Camera, G. Vella, A. Law, M. Marchioni, D. Mehn, O. Geiss, B. Peacock, D. Aubert, L. Calzolai, F. Caputo, A. Prina‐Mello. J. Extracell. Vesicles, 10, N 3 (2021) e12052, doi: 10.1002/jev2.120521</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">V. E. Vaskovsky, E. Y. Kostetsky, J. M. Vasendin. J. Chromatography, 114, N 1 (1975) 129—141</mixed-citation><mixed-citation xml:lang="en">V. E. Vaskovsky, E. Y. Kostetsky, J. M. Vasendin. J. Chromatography, 114, N 1 (1975) 129—141</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">L. Birichevskaya, M. Vinter, N. Litvinko, A. Zinchenko. Chem. Biochem. Res. (2020), doi: 0./SAMI/CBR.2020</mixed-citation><mixed-citation xml:lang="en">L. Birichevskaya, M. Vinter, N. Litvinko, A. Zinchenko. Chem. Biochem. Res. (2020), doi: 0./SAMI/CBR.2020</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">В. В. Лысак, Р. А. Желдакова, О. В. Фомина. Микробиология. Практикум: пособие, Минск, БГУ (2015)</mixed-citation><mixed-citation xml:lang="en">В. В. Лысак, Р. А. Желдакова, О. В. Фомина. Микробиология. Практикум: пособие, Минск, БГУ (2015)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Н. М. Литвинко. Весцi НАН Беларусi, Сер. хiм. навук, 58, № 1 (2022) 105—128</mixed-citation><mixed-citation xml:lang="en">Н. М. Литвинко. Весцi НАН Беларусi, Сер. хiм. навук, 58, № 1 (2022) 105—128</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">A. Tupin, M. Gualtieri, F. Roquet-Baneres, Z. Morichaud, K. Brodolin, J. Leonetti. Int. J. Antimicrob. Agents, 35 (2010) 519—523</mixed-citation><mixed-citation xml:lang="en">A. Tupin, M. Gualtieri, F. Roquet-Baneres, Z. Morichaud, K. Brodolin, J. Leonetti. Int. J. Antimicrob. Agents, 35 (2010) 519—523</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">D. O. Gerlovsky, N. M. Litvinko, I. A. Mikhailopulo, L. L. Birichevskaya, A. I. Zinchenko. VII Int. Conf. Chemistry, Structure and Function of Biomolecules, Minsk, November 23—25 (2021) 3</mixed-citation><mixed-citation xml:lang="en">D. O. Gerlovsky, N. M. Litvinko, I. A. Mikhailopulo, L. L. Birichevskaya, A. I. Zinchenko. VII Int. Conf. Chemistry, Structure and Function of Biomolecules, Minsk, November 23—25 (2021) 3</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
